Current Opinion in Oncology
Published by Wolters Kluwer Health
ISSN : 1040-8746 eISSN : 1531-703X
Abbreviation : Curr. Opin. Oncol.
Aims & Scope
With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors.
Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year.
This is supplemented by annotated references detailing the merits of the most important papers.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.4 |
2024 | 2.80 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.123 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 106 |
Journal Rank
Year | Value |
---|---|
2024 | 3987 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 771 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
TGF-β signaling and epithelial–mesenchymal transition in cancer progression
Citation: 666
Authors: Yoko, Samy, Rik
-
Histone deacetylase inhibitors as new cancer drugs
Citation: 433
Authors: Paul A., Victoria M., Ronald, Richard A.
-
Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
Citation: 351
Authors: John C.